Staff and wire reportsPotential Alzheimer's drug gets cautious reviewSome of the nation's top neuroscientists responded with cautious optimism to a detailed presentation Thursday from pharmaceutical company Biogen about an experimental drug that appears to slow the brain's deterioration in the early stages of Alzheimer's disease.Read more on NewsOK.com